Lichtner RB - Search Results

1

Total synthesis and antitumor activity of ZK-EPO: the first fully synthetic epothilone in clinical development.

Klar U, Buchmann B, Schwede W, Skuballa W, Hoffmann J, Lichtner RB. Klar U, et al. Among authors: lichtner rb. Angew Chem Int Ed Engl. 2006 Dec 4;45(47):7942-8. doi: 10.1002/anie.200602785. Angew Chem Int Ed Engl. 2006. PMID: 17006870 No abstract available.

2

Improved cellular pharmacokinetics and pharmacodynamics underlie the wide anticancer activity of sagopilone.

Hoffmann J, Vitale I, Buchmann B, Galluzzi L, Schwede W, Senovilla L, Skuballa W, Vivet S, Lichtner RB, Vicencio JM, Panaretakis T, Siemeister G, Lage H, Nanty L, Hammer S, Mittelstaedt K, Winsel S, Eschenbrenner J, Castedo M, Demarche C, Klar U, Kroemer G. Hoffmann J, et al. Among authors: lichtner rb. Cancer Res. 2008 Jul 1;68(13):5301-8. doi: 10.1158/0008-5472.CAN-08-0237. Cancer Res. 2008. PMID: 18593931

3

Subcellular distribution of epothilones in human tumor cells.

Lichtner RB, Rotgeri A, Bunte T, Buchmann B, Hoffmann J, Schwede W, Skuballa W, Klar U. Lichtner RB, et al. Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11743-8. doi: 10.1073/pnas.171023398. Epub 2001 Sep 18. Proc Natl Acad Sci U S A. 2001. PMID: 11562452 Free PMC article.

4

Studies on the development of resistance to the pure antiestrogen Faslodex in three human breast cancer cell lines.

Sommer A, Hoffmann J, Lichtner RB, Schneider MR, Parczyk K. Sommer A, et al. Among authors: lichtner rb. J Steroid Biochem Mol Biol. 2003 May;85(1):33-47. doi: 10.1016/s0960-0760(03)00139-0. J Steroid Biochem Mol Biol. 2003. PMID: 12798355

5

Signaling-inactive epidermal growth factor receptor/ligand complexes in intact carcinoma cells by quinazoline tyrosine kinase inhibitors.

Lichtner RB, Menrad A, Sommer A, Klar U, Schneider MR. Lichtner RB, et al. Cancer Res. 2001 Aug 1;61(15):5790-5. Cancer Res. 2001. PMID: 11479217

6

Characterization of new estrogen receptor destabilizing compounds: effects on estrogen-sensitive and tamoxifen-resistant breast cancer.

Hoffmann J, Bohlmann R, Heinrich N, Hofmeister H, Kroll J, Künzer H, Lichtner RB, Nishino Y, Parczyk K, Sauer G, Gieschen H, Ulbrich HF, Schneider MR. Hoffmann J, et al. Among authors: lichtner rb. J Natl Cancer Inst. 2004 Feb 4;96(3):210-8. doi: 10.1093/jnci/djh022. J Natl Cancer Inst. 2004. PMID: 14759988

7

Differential cross-talk of estrogen and growth factor receptors in two human mammary tumor cell lines.

Lichtner RB, Parczyk K, Birchmeier W, Schneider MR. Lichtner RB, et al. J Steroid Biochem Mol Biol. 1999 Dec 31;71(5-6):181-9. doi: 10.1016/s0960-0760(99)00136-3. J Steroid Biochem Mol Biol. 1999. PMID: 10704907

8

Prevention of EGF-modulated adhesion of tumor cells to matrix proteins by specific EGF receptor inhibition.

Genersch E, Schneider DW, Sauer G, Khazaie K, Schuppan D, Lichtner RB. Genersch E, et al. Among authors: lichtner rb. Int J Cancer. 1998 Jan 19;75(2):205-9. doi: 10.1002/(sici)1097-0215(19980119)75:2<205::aid-ijc7>3.0.co;2-y. Int J Cancer. 1998. PMID: 9462709

9

Selective increase of alpha2-integrin sub-unit expression on human carcinoma cells upon EGF-receptor activation.

Krensel K, Lichtner RB. Krensel K, et al. Among authors: lichtner rb. Int J Cancer. 1999 Feb 9;80(4):546-52. doi: 10.1002/(sici)1097-0215(19990209)80:4<546::aid-ijc11>3.0.co;2-9. Int J Cancer. 1999. PMID: 9935155

10

Antimetastatic action of the prostacyclin analogue cicaprost in experimental mammary tumors.

Schneider MR, Schirner M, Lichtner RB, Graf H. Schneider MR, et al. Among authors: lichtner rb. Breast Cancer Res Treat. 1996;38(1):133-41. doi: 10.1007/BF01803791. Breast Cancer Res Treat. 1996. PMID: 8825130 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

50 results

Search Page

Filters